AzTrials
AzTrials

EmesisNCT01509417

Different Feeding Methods After Pyloromyotomy

A study testing ad lib feedings after pyloromyotomy and FLAP diet after pyloromyotomy in people with Emesis, run by Children's Mercy Hospital Kansas City at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this study is to scientifically evaluate the ability to discharge patients based on feeding schedule comparing ad lib feeds to our current scheduled regimen. The hypothesis is that patients may be able to be discharged sooner with ad lib feeds. Read more about this study

Who is it for?
Ages 1 day to 3 months
Conditions the study is for
Emesis
What is being tested?
ad lib feedings after pyloromyotomy and FLAP diet after pyloromyotomy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteUnited States
Study dates
Jul 2010to Feb 2012
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 day to 3 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Patients who are diagnosed with pyloric stenosis and scheduled for laparoscopic pyloromyotomy. -

Who cannot join

  • Open procedures
  • Patient has alternative diagnosis that would affect feeding (like mucosal perforation)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Children's Mercy Hospital

    Kansas City, Missouri, 64108

Other trials in United States

About this study

Official title: Prospective Randomized Trial Evaluating the Feeding Regimen After Pyloromyotomy.

The objective of this study is to scientifically evaluate the ability to discharge patients based on feeding schedule comparing ad lib feeds to our current scheduled regimen.

The hypothesis is that patients may be able to be discharged sooner with ad lib feeds.

Read the detailed description

Hypertrophic pyloric stenosis is a common disease occurring in 2 per 1,000 live births1. Pyloric stenosis is a hypertrophy of the pyloric muscle which prevents emptying of the stomach leading to gastric outlet obstruction. The vomiting that ensues becomes projectile and results in severe dehydration. Traditionally this has been repaired with the pyloromyotomy via a transverse incision in the right upper quadrant. In the last decade the investigators have started doing the same procedure laparoscopically. Most institutions follow similar guidelines as to what constitutes a hypertrophic pyloric channel, initial electrolyte management and resuscitation prior to surgery, as well as the pyloromyotomy (either open or laparoscopically).

Historically patients were fed the day after surgery, then 6 hours, and currently the investigators wait 2 hours after surgery to start feeds. The investigators go through a protocol of 2 rounds of clear liquids, 2 rounds of half strength formula/breast milk then 2 rounds of full strength. Some centers have advocated ad lib feeds where babies go straight to full strength as tolerated when awake from the operation.

Institutional variability is even further confounded by individual attending variability in some instances. Recent articles in the past two decades still prove that no consensus has been found. Some institutions profess that Ad Libitum feeding is both cost-effective as well as safe, but very few institutions to our knowledge follow this mantra. Others demand that no feeds should be started within 4 hours post surgery stating that the increased vomiting associated with this early feeding regimen actually prolongs the time to full feeds due to anxiety and discomfort. What has been shown is that no matter whether patients start 4 hours post surgery or wait 18 hours the time to full feeds is the same. All of these studies are hindered by the fact that they all have retrospective components to their design.

What has also been propagated in two recent retrospective reviews is the implementation of clinical pathways as well as standardized feeding regimens. Both of these showed a decrease in length of stay postoperatively as well as hospital costs.

At our institution a clinical pathway and feeding regimen has been implemented. The feeding regimen contrary to some of the previously quoted papers starts at 2 hours with sequential feeding increases. A prospectively acquired dataset at our institution has shown that emesis is correlated to the degree of dehydration of the child prior to surgery even with all the children being on the same clinical pathway.

What all of these studies show us is that as a profession, Pediatric Surgery does not have the proper evidence to support any one post-op feeding regimen.

Conditions
Emesis
Being tested
ad lib feedings after pyloromyotomy, FLAP diet after pyloromyotomy
Keywords
pyloric stenosis
Medical subject headings
Vomiting, Pyloric Stenosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ad lib feedings after pyloromyotomyOther

    Also called post surgical refeeding ad lib

    ad lib feedings after pyloromyotomy

  • FLAP diet after pyloromyotomyOther

    Also called Post surgical FLAP refeeding

    FLAP diet after pyloromyotomy

Study groups in NCT01509417
Study groupRoleWhat they receive
Ad lib feedingExperimentalad lib feedings following pyloromyotomy
Receives: Other: ad lib feedings after pyloromyotomy; Other: FLAP diet after pyloromyotomy
FLAP diet after pyloromyotomyActive comparatorFLAP diet after pyloromyotomy
Receives: Other: FLAP diet after pyloromyotomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Length of hospital stay

    Measured: up to 10 days

Secondary outcomes (1)
  1. number of emeses during stay

    Measured: up to 10 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2012 (estimated)
  2. Study startJul 2010
  3. Primary completionJan 2012
  4. Study completionFeb 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01509417
Sponsor's protocol ID
10 05-101
Status last verified
May 2013
First submitted
14 Dec 2011
Last updated
29 May 2013
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing ad lib feedings after pyloromyotomy and FLAP diet after pyloromyotomy in people with Emesis, run by Children's Mercy Hospital Kansas City at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 May 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Length of hospital stay (time frame: up to 10 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2013.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in